A Phase 1/2 Study of 124I-NM404 in Subjects With Advanced Solid Malignancies
Phase of Trial: Phase I/II
Latest Information Update: 01 Feb 2017
Price : $35 *
At a glance
- Drugs CLR 1404 I-124 (Primary)
- Indications Breast cancer; Colorectal cancer; Gastric cancer; Head and neck cancer; Male breast cancer; Oesophageal cancer; Ovarian cancer; Pancreatic cancer; Prostate cancer; Soft tissue sarcoma
- Focus Diagnostic use
- 16 May 2016 Status changed from active, no longer recruiting to discontinued as sponsor determined this trial does not support their anticipated clinical development program.
- 21 Aug 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 30 Apr 2015 Status changed from suspended to recruiting as reported by ClinicalTrials.gov